Efficacy and safety of intravenous amiodarone in recent-onset atrial fibrillation: Experience in patients admitted to a general internal medicine department

Postgraduate Medical Journal

Volumn 75, Issue 883, 1999, Pages 278-281

  Kreiss, Yitshak ^b   Sidi, Yechezkel ^b   Gur, Hanan ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b NONE

Author keywords

Amiodarone; Atrial fibrillation

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; SINUS RHYTHM; THROMBOPHLEBITIS;

EID: 0032893707     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.75.883.278     Document Type: Article

References (30)

1. Roden DM. Risks and benefits of antiarrhythmic therapy. N Engl J Med 1994;331:785-91.
2. Boriani G, Biffi M, Capucci A, et al. Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease. A randomized, controlled trial. Ann Intern Med 1997;126:621-5.
3. Capucci A, Boriani G, Rubino I, et al. A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythm. Int J Cardiol 1994;43:305-15.
4. Marcus FI. The hazards of using type 1C antiarrhythmic drugs for the treatment of paroxysmal atrial fibrillation. Am J Cardiol 1990;66:366-7.
5. Feld GK, Chen PS, Nicod P, et al. Possible atrial proarrhythmic effects of class 1C antiarrhythmic drugs. Am J Cardiol 1990;66:378-83.
6. Hou ZY, Chang MS, Chen CY, et al. Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone. A randomized, digoxin-controlled study. Eur Heart J 1995;16:521-8.
7. Blandford RL, Crampton J, Kudlac H. Intravenous amiodarone in atrial fibrillation complicating myocardial infarction. BMJ 1982;284:16-7.
8. Strasberg B, Arditti A, Scalorovski S, et al. Efficacy of intravenous amiodarone in the management of paroxysmal or new atrial fibrillation with fast ventricular response. Int J Cardiol 1985;7:47-55.
9. Holt P, Crick JCP, Davies DW, et al. Intravenous amiodarone in the acute termination of supraventricular arrhythmia. Int J Cardiol 1985;8:67-76.
10. Noc M, Stajer D, Horvat M. Intravenous amiodarone versus verapamil for acute conversion of paroxysmal atrial fibrillation to sinus rhythm. Am J Cardiol 1990;65:679-80.
11. McAllister HF, Luke RA, Whitlock RM, et al. Intravenous amiodarone bolus versus oral quinidine for atrial flutter and fibrillation after cardiac operation. J Thorac Cardiovasc Surg 1990;99:911-918.
12. Vietti-Ramus G, Veglio F, Marchisio U, et al. Efficacy and safety of short intravenous amiodarone in supraventricular tachyarrhythmia. Int J Cardiol 1992;35:77-85.
13. Galve E, Rius T, Ballester R, et al. Intravenous amiodarone in the treatment of recent-onset atrial fibrillation: results of a randomized controlled study. J Am Coll Cardiol 1996;27:1079-82.
14. Desai A, Chun S, Sung R. The role of intravenous amiodarone in the management of cardiac arrhythmias. Ann Intern Med 1997;127:294-303.
15. Clara F. Intravenous amiodarone in atrial fibrillation complicating myocardial infarction. BMJ 1982;284:506-7.
16. Schwartz A, Shen E, Morady F, et al. Hemodynamic effects of intravenous amiodarone in patients with depressed left ventricular function and recurrent ventricular tachycardia Am Heart J 1983;106:848-56.
17. Leroy G, Haiat R, Barthelemy M, et al. Torsade de pointes during loading with amiodarone. Eur Heart J 1987;8:541-3.
18. Brown MA, Smith WM, Lubbe WF, et al. Amiodarone-induced torsades de pointes. Eur Heart J 1986;7:234-9.
19. Chapman MJ, Moran JL, O'Fathartaigh MS, et al. Management of atrial tachyarrhythmia in the critically ill: a comparison of intravenous procaineamide and amiodarone. Intern Care Med 1993;19:58-2.
20. Cybulski J, Kulakowski P, Makowska E, et al. Intravenous amiodarone is safe and seems to be effective in termination of paroxysmal supraventricular tachyarrhythmias. Clin Cardiol 1996;19:563-6.
21. Kumar A. Intravenous amiodarone for therapy of atrial fibrillation and flutter in critically ill patients with severely depressed left ventricular function. South Med J 1996;89: 779-85.
22. Hohnloser SH, Meinetz T, Dammbacher T, et al. Electrocardiographic and antiarrhythmic effects of intravenous amiodarone: results of a prospective, placebo-controlled study. Am Heart J 1991;121:89-95.
23. Donovan KD, Power BM, Hockings BEF, et al. Intravenous flecainide versus amiodarone for recent-onset atrial fibrillation. Am J Cardiol 1995;75:693-7.
24. Kerin NZ, Faitel K, Naini M. The efficacy of intravenous amiodarone for the conversion of chronic atrial fibrillation. Amiodarone vs quinidine for conversion of atrial fibrillation. Arch Int Med 1996;156:49-53.
25. Singh BN, Venkatesh N, Nademanee K, et al. The historical development, cellular electrophysiology, and pharmacology of amiodarone. Prog Cardiovasc Dis 1989;31:249-80.
26. Wellens HJ, Brugada P, Abdollah H, et al. A comparison of the electrophysiologic effects of intravenous and oral amiodarone in the same patient. Circulation 1984;69:120-4.
27. Morady F, DiCarlo LA Jr, Krol RB, et al. Acute and chronic effects of amiodarone on ventricular refractoriness, intraventricular conduction and ventricular tachycardia induction. J Am Coll Cardiol 1986;7:148-56.
28. Yabek SM, Kato R, Singh BN. Effects of amiodarone and its metabolite desethylamiodarone, on the electrophysiologic properties of isolated cardiac muscle. J Cardiovasc Pharmacol 1986;8:197-207.
29. Mayuga RD, Singer DH. Effects of intravenous amiodarone on electrical dispersion in normal and ischaemic tissues and on arrhythmia inducibility: monophasic action potential studies. Cardiovasc Res 1992;20:571-9.
30. Mason JW, Hondeghem LM, Katzung BJ. Block of inactivated sodium channels and of depolarization-induced automaticity in guinea pig papillary muscle by amiodarone. Circulat Res 1984;55:277-87.